Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2-Syria, 2017-2018

被引：22

作者：

Mbaeyi, Chukwuma ^{[1
]}

Wadood, Zubair Mufti ^{[2
]}

Moran, Thomas ^{[2
]}

Ather, Fazal ^{[3
]}

Stehling-Ariza, Tasha ^{[4
]}

Nikulin, Joanna ^{[2
]}

Al Safadi, Mohammad ^{[2
]}

Iber, Jane ^{[5
]}

Zomahoun, Laurel ^{[1
]}

Abourshaid, Nidal ^{[6
]}

Pang, Hong ^{[5
]}

Collins, Nikki ^{[5
]}

Asghar, Humayun ^{[2
]}

Butt, Obaid ul Islam ^{[2
]}

Burns, Cara C. ^{[5
]}

Ehrhardt, Derek ^{[1
]}

Sharaf, Magdi ^{[2
]}

机构：

[1] CDC, Global Immunizat Div, Ctr Global Hlth, Atlanta, GA 30333 USA

[2] WHO, Polio Eradicat Dept, Geneva, Switzerland

[3] United Nations Childrens Fund, Middle East & North Africa Off, Amman, Jordan

[4] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA

[5] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA

[6] United Nations Childrens Fund, Syria Country Off, Damascus, Syria

来源：

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2018年 / 67卷 / 24期

关键词：

PROGRESS; ERADICATION; WORLDWIDE;

D O I：

10.15585/mmwr.mm6724a5

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

What is already known about this topic? Oral poliovirus vaccine (OPV) contains live attenuated viruses, which rarely revert to neurovirulence. These vaccine-derived polioviruses (VDPVs) tend to emerge in populations with low OPV coverage and are capable of causing paralysis. What is added by this report? In 2017, an outbreak of circulating VDPV type 2 (cVDPV2) occurred in Syria, causing 74 cases. Implementation of three rounds of monovalent OPV type 2 campaigns coupled with intensified surveillance interrupted the outbreak. What are the implications for public health practice? The outbreak in Syria underscores the risk for emergence of vaccine-derived polioviruses in settings of low OPV coverage. High-quality surveillance and targeted vaccination using monovalent OPV type 2 are effective in controlling cVDPV2 outbreaks. © 2018, Department of Health and Human Services. All Rights reserved.

引用

页码：690 / 694

页数：5

共 50 条

[21] Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria
Sun, Yuming
Keskinocak, Pinar
Steimle, Lauren N.
Kovacs, Stephanie D.
Wassilak, Steven G.
VACCINE: X, 2024, 18
[22] Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021
Yang, Hong
Qi, Qi
Zhang, Yong
Wen, Ning
Cao, Lei
Liu, Yu
Fan, Chunxiang
Yan, Dongmei
Zhu, Xiaoping
Hao, Lixin
Zhu, Shuangli
Ma, Qianli
Liu, Jiajie
Ma, Chao
Nan, Lei
Chen, Yong
Ma, Xiaozhen
Chen, Na
Deng, Kun
Shao, Ge
Ding, Xianxiang
An, Zhijie
Rodewald, Lance E.
Li, Xiaolei
Wang, Dongyan
Zhu, Hui
Wang, Huaqing
Feng, Zijian
Xu, Wenbo
Zhou, Jiushun
Yin, Zundong
JAMA NETWORK OPEN, 2023, 6 (01) : E2249710
[23] Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021
Alleman, Mary M.
Jorba, Jaume
Riziki, Yogolelo
Henderson, Elizabeth
Mwehu, Anicet
Seakamela, Lerato
Howard, Wayne
Mbule, Albert Kadiobo
Nsamba, Renee Ntumbannji
Djawe, Kpandja
Yapi, Moise Desire
Mengouo, Marcellin Nimpa
Gumede, Nicksy
Ndoutabe, Modjirom
Kfutwah, Anfumbom K. W.
Senouci, Kamel
Burns, Cara C.
VACCINE, 2023, 41 : A35 - A47
[24] A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan-2020 to 2021
Tegegne, Ayesheshem Ademe
Anyuon, Atem Nathan
Legge, George Awzenio
Ferede, Melisachew Adane
Isaac, Zingbondo
Laku, Kirbak Anthony
Biadgilign, Sibhatu
Kilo, Ochan Taban David
Ndenzako, Fabian
Modjirom, Ndoutabe
Olu, Olushayo Oluseun
Maleghemi, Sylvester
BMC INFECTIOUS DISEASES, 2023, 23 (01)
[25] Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use - Six African Countries, 2021-2023
Davlantes, Elizabeth
Jorba, Jaume
Henderson, Elizabeth
Bullard, Kelley
Deka, Mark. A.
Kfutwah, Anfumbom
Martin, Javier
Bessaud, Mael
Shulman, Lester M.
Hawes, Kaija
Diop, Ousmane M.
Bandyopadhyay, Ananda S.
Zipursky, Simona
Burns, Cara C.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (38): : 1041 - 1042
[26] Detection and Initial Response to a Type 2 Vaccine-Derived Poliovirus - Sichuan Province, China, 2019
Zhou, Jiushun
Wen, Ning
Zhang, Yong
Qi, Qi
Fan, Chunxiang
Yan, Dongmei
Zhu, Xiaoping
Hao, Lixin
Zhu, Shuangli
Liu, Yu
Ma, Xiaozhen
Ma, Chao
Nan, Lei
Chen, Yong
Ma, Qianli
Wang, Cheng
Deng, Kun
Cao, Lei
Shao, Ge
Ding, Xianxiang
Yang, Hong
An, Zhijie
Rodewald, Lance E.
Xu, Aiqiang
Wang, Huaqing
Feng, Zijian
Yin, Zundong
Wu, Xianping
Xu, Wenbo
CHINA CDC WEEKLY, 2020, 2 (11): : 172 - 175
[27] Preventing paralytic polio caused by vaccine-derived poliovirus type 2
Franco-Paredes, Carlos
Santos-Preciado, Jose I.
Henao-Martinez, Andres F.
Rodriguez-Morales, Alfonso J.
Carrasco, Peter
LANCET INFECTIOUS DISEASES, 2020, 20 (01): : 21 - 22
[28] Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study
Cooper, Laura, V
Erbeto, Tesfaye B.
Danzomo, Abba A.
Abdullahi, Hamisu W.
Boateng, Kofi
Adamu, Usman S.
Shuaib, Faisal
Modjirom, Ndoutabe
Gray, Elizabeth J.
Bandyopadhyay, Ananda S.
Zipursky, Simona
Okiror, Samuel
Grassly, Nicholas C.
Blake, Isobel M.
LANCET INFECTIOUS DISEASES, 2024, 24 (04): : 427 - 436
[29] Halting vaccine-derived poliovirus circulation: the novel type 2 oral vaccine might not be enough
Nyenswah, Tolbert G.
Schue, Jessica L.
LANCET GLOBAL HEALTH, 2023, 11 (06): : E811 - E812
[30] Poliovirus-Neutralizing Antibody Seroprevalence and Vaccine Habits in a Vaccine-Derived Poliovirus Outbreak Region in the Democratic Republic of Congo in 2018: The Impact on the Global Eradication Initiative
Halbrook, Megan
Gadoth, Adva
Mukadi, Patrick
Hoff, Nicole A.
Musene, Kamy
Dzogang, Camille
Sinai, Cyrus Shannon
Spencer, D'Andre
Ngoie-Mwamba, Guillaume
Tangney, Sylvia
Salet, Frank
Nyembwe, Michel
Nzaji, Michel Kambamba
Tambu, Merly
Mbala, Placide
Fuller, Trevon
Gerber, Sue K.
Kaba, Didine
Muyembe-Tamfum, Jean Jacques
Rimoin, Anne W.
VACCINES, 2024, 12 (03)

← 1 2 3 4 5 →